Companies Related to "Nelfinavir in Recurrent Adenoid Cystic Cancer of the Head and Neck" [Most Relevant Company Matches] RSS

04:48 EST 21st February 2019 | BioPortfolio

Here are the most relevant search results for "Nelfinavir in Recurrent Adenoid Cystic Cancer of the Head and Neck" found in our extensive corporate database of over 50,000 company records.

Showing "Nelfinavir Recurrent Adenoid Cystic Cancer Head Neck" Companies 1–25 of 2,700+

Extremely Relevant

Head and Neck Cancer Alliance

Oral, head & neck cancer (OHNC) refers to a variety of cancers that develop in the head and neck region, such as: the oral cavity (mouth); the pharynx (throat); paranasal sinuses and nasal cavity; the larynx (voice box); thyroid and salivary glands; the skin of the face and neck; and the lymph nodes in the neck.

Genetronics Biomedical

Genetronics' most advanced effort involves treating those with head and neck cancer, a particularly devastating cancer that can severely limit the ability of these patients to see, taste, hear, talk, breathe, or swallow. Genetronics received approval from the U.S. Food and Drug Administration and initiated Phase II multi-center clinical trials at nine sites in the U.S. The trials test the effectiv...

Head and Neck Surgery Associates

Head and Neck Surgery Associates in Indianapolis, IN provide the latest and most advanced treatment of diseases involving the head and neck. Meet our doctors and learn about their expertise as well as the diseases they treat.


Ayala Pharmaceuticals, Inc.

Ayala Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company dedicated to developing targeted cancer therapies for people living with genetically defined cancers. Ayala is broadly developing its product candidates, AL101 and AL102, best-in-class gamma secretase inhibitors, with clinical and nonclinical studies underway in both solid tumors (AL...

Dr.Stephan Ariyan

Dr. Stephan Ariyan is a Clinical Professor of Surgery, Plastic Surgery, and Otolaryngology at Yale University School of Medicine and Director, Yale Cancer Center Melanoma Unit. He was Professor and Chairman of Plastic Surgery at Yale from 1979 to 1991. At that time, he returned to the Graduate School of Business at the University of New Haven and earned an MBA in 1993.ternationally known surgeon, ...

European Head and Neck Society

The European Head and Neck Society

The Rontal Clinic

The Rontal Clinic was started in 1972 after Doctors Michael and Eugene Rontal assumed an existing practice from Dr. Jerome Hauser that dated back to the late 1930’s. Both physicians had strong roots in the Detroit area, attending Cooley High School, graduating from the University of Michigan Medical School, and interning at Sinai Hospital of Detroit. After completing their internship, they each ...


GeneSegues is a biopharmaceutical company built upon advanced, targeted drug delivery technology. We conduct research and early-stage development of proprietary oncology biopharmaceuticals using our ligand-directed, nanoencapsulation technology. Our two initial product candidates are antisense therapeutics for treatment of advanced head neck and prostate cancers. We are currently conducting animal...

American Academy of Otolaryngology – Head and Neck Surgery

American Academy of Otolaryngology – Head and Neck Surgery (AAO-HNS)

CEL-SCI Corporation

CEL-SCI Corporation is developing products that empower immune defenses. Its lead product is Multikine. In Phase II clinical trials Multikine was shown to be safe and well-tolerated, and to improve the patients' overall survival by 33 percent at a median of three and a half years following surgery. A pivotal Phase III clinical trial with Multikine in head ...

YM BioSciences Inc

YM BioSciences Inc. is an oncology company that identifies, develops and commercializes differentiated products for patients worldwide. The Company is advancing two late-stage products: nimotuzumab, a humanized monoclonal antibody that targets the epidermal growth factor receptor (EGFR) and is approved in several countries for treatment of various types of head and neck cancer; and AeroLEF™, a p...

Vigilant Biosciences, Inc.

Vigilant Biosciences, Inc. is a medical technology company enabling screening and early intervention to avoid the adverse outcomes associated with life threatening illness. The company’s initial product development initiatives are centered on head and neck cancer screening technologies using quick and straightforward sample collection and detection me...

Prostate Cancer Foundation

The Prostate Cancer Foundation (PCF) is the world’s largest philanthropic source of support for accelerating the world’s most promising research for discovering better treatments and cures for prostate cancer. Founded in 1993, the PCF has raised nearly $400 million and provided funding to more than 1,500 researchers at nearly 200 institutions wor...


GeneMax develops innovative immunotherapies in the fields of oncology and infectious disease. Our patented technology restores or increases antigen processing and antigen specific immune responses. GeneMax has demonstrated preclinical efficacy in animal models of lung cancer and melanoma as well as proof of principle for infectious disease pathogens.GeneMax’s program also includes developing a t...

ENT & Allergy Associates

Each of ENT and Allergy Associates’ 36 clinical locations provides access to a full complement of services, including General Adult and Pediatric ENT, Voice and Swallowing, Facial Plastics and Reconstructive Surgery, Disorders of the Inner Ear and Dizziness, Asthma, Clinical Immunology, Diagnostic Audiology, Hearing Aid dispensing, Sleep and CT servic...

Kapitex Healthcare Ltd

Kapitex is a specialist company focussing on Head and Neck cancer and airway management for laryngectomy and tracheostomy patients. The Company has an excellent reputation for product quality and service with an enviable record for delivering products to very short lead times.Kapitex is a small, rapidly expanding privately owned limited company. Established in 1991, Kapitex is science based and cl...

ENT and Allergy Associates LLP

Each of ENT and Allergy Associates’ 36 clinical locations provides access to a full complement of services, including General Adult and Pediatric ENT, Voice and Swallowing, Facial Plastics and Reconstructive Surgery, Disorders of the Inner Ear and Dizziness, Asthma, Clinical Immunology, Diagnostic Audiology, Hearing Aid dispensing, Sleep and CT servic...

Viventia Biotech Inc

Viventia Biotech Inc. is a biopharmaceutical company advancing a new generation of monoclonal antibody therapeutics designed to offer safer, more beneficial therapies for cancer patients. Viventia’s lead product candidate Proxinium™ continues on an aggressive clinical development schedule. Viventia has initiated a Phase II North American clinical trial and concurrently commenced a pivotal Phas...

Cystic Fibrosis Foundation

The Cystic Fibrosis Foundation is the world's leader in the search for a cure for cystic fibrosis. The Foundation funds more CF research than any other organization and nearly every CF drug available today was made possible because of Foundation support. Based in Bethesda, Md., the Foundation also supports and accredits a national care center network that has been recognized by the National Instit...

YM BioSciences

YM BioSciences is a product development company. Our focus is to advance cancer products along the regulatory and clinical pathways towards commercial approval. YMB does not conduct basic research; rather, our product portfolio is established through a process of careful, rational selection of therapeutics produced in research institutions around the globe. We have one of the broadest oncology po...

Nucletron B.V.

Nucletron is a radiotherapy company that specializes in the development, manufacture, sales, service and support of the world's most innovative products for cancer treatment. As a company, our guiding principle is the customer's demand for quality, safety and reliability. We continuously invest in innovative research and development. This approach has made it possible to successfully treat cancers...

Cystic Fibrosis Foundation, Northern Ohio Chapter

The Northern Ohio Chapter of the Cystic Fibrosis Foundation works to help develop a means to control and cure cystic fibrosis and to improve the lives of those with the disease. The chapter serves 28 counties throughout Northern Ohio.

Cystic Fibrosis Trust

•        Cystic fibrosis is chronically misunderstood, kills thousands worldwide and is carried unknowingly in the genes of millions. It's often invisible to the naked eye yet destroys lives, stopping them short, inflicting hardship and distress on patients, their families and carers. Cystic fibrosis directly affects around 10,000 people in the UK. &b...

More From BioPortfolio on "Nelfinavir in Recurrent Adenoid Cystic Cancer of the Head and Neck"

Quick Search


Corporate Database Quicklinks